The level of chemokine CXCL13 in the cerebrospinal fluid of patients with NMO is related to the degree of NMO-related nerve defect (7), and patients with recurrence tend to have higher levels of CXCL13 in the serum and cerebrospinal fluid (CSF). Here, CXCL13 is linked to neuromyelitis optica.